Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03779997 · ClinicalTrials.gov registry record · NA
Trial of Adherence App for Buprenorphine Treatment (TAAB) Study
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT03779997 is a NA study that has completed, run by University of Washington. The registered enrollment target is 78 participants.
The verdict
NCT03779997, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
The purpose of this study is to pilot test a smartphone application that allows video-based directly observed therapy for participants receiving buprenorphine treatment for opioid use disorder in office-based settings. This application may help participants take their medication more regularly so that they are successful in treatment. Participants will be randomly assigned to either using a smartphone application that allows them to take daily videos confirming their buprenorphine medication ingestion or they will continue with their care as usual (treatment-as-usual or TAU). The primary study outcome will be the percentage of weekly study urine drug tests that are negative for opiates between baseline and 12 weeks post-randomization. The secondary outcome will be engagement in treatment at week 12.
Interventions
- BEHAVIORAL Video-based DOT Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2019-02-15 |
| Est. Completion | 2020-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03779997
The ClinicalTrials.gov registry entry for NCT03779997 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Video-based DOT Application is the first listed.
NCT03779997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03779997 about?
NCT03779997 is a clinical study titled "Trial of Adherence App for Buprenorphine Treatment (TAAB) Study". The purpose of this study is to pilot test a smartphone application that allows video-based directly observed therapy for participants receiving buprenorphine treatment for opioid use disorder in office-based settings. This application may help participants take their medication more regularly so th...
What is the current status of trial NCT03779997?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2019-02-15. Estimated completion is 2020-07-29.
What interventions are being tested in trial NCT03779997?
The interventions under investigation include: Video-based DOT Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT03779997?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.